Ixekizumab: A Review of Its Use for the Management of Moderate to Severe Plaque Psoriasis
- 6 September 2018
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 53 (3), 276-284
- https://doi.org/10.1177/1060028018799982
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 46 references indexed in Scilit:
- A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisJournal of the American Academy of Dermatology, 2014
- Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasisThe Journal of Clinical Pharmacology, 2014
- Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasisBritish Journal of Dermatology, 2013
- Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social LifeActa Dermato Venereologica, 2012
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque PsoriasisNew England Journal of Medicine, 2012
- Consensus Guidelines for the Management of Plaque PsoriasisArchives of Dermatology, 2012
- Guidelines of care for the management of psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2011
- LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept studyArthritis & Rheumatism, 2010
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agentsJournal of the American Academy of Dermatology, 2009
- Guidelines of care for the management of psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2008